Earn CME: https://naccme.com/program/7334
In this presentation from the ‘Keeping Up With CAR T-cell Therapies in B-Cell Lymphomas’ symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Matthew J. Frigault discusses best practices for the management of cytokine release syndrome (CRS) and neurotoxicity when utilizing CAR-T therapy.
© 2019 Imedex, an HMP Company
Advertisement